The European Bank for Reconstruction and Development (EBRD) is supporting the expansion of Big-Family-Pharm (BFP), the operator of the Akmal Pharm pharmacy chain, through a loan of up to US$10 million. The investment aims to improve access to licensed medicines and healthcare services across Uzbekistan, particularly in the Fergana Valley region.
BFP currently operates 86 pharmacies in the Tashkent, Andijan, and Fergana regions. The funding will enable the company to open 100 additional pharmacies, renovate facilities, purchase specialized equipment, and expand the availability of medicines. This expansion is expected to strengthen healthcare access for communities and support the country’s growing pharmaceutical sector.
The project also focuses on improving quality standards and transparency. BFP plans to adopt the World Health Organization’s Good Pharmacy Practice (GPP) standards, ensuring evidence-based pharmaceutical care and better customer service. With EBRD technical assistance, the company will introduce employee training programs covering pharmacy standards and professional skills while modernizing and digitalizing its training center.
The initiative reflects EBRD’s broader commitment to supporting private sector development and healthcare improvements in Uzbekistan. The bank has invested nearly US$6.9 billion in the country through more than 200 projects, helping strengthen entrepreneurship, economic growth, and access to essential services.
